US Stock MarketDetailed Quotes

Cogent Biosciences (COGT)

Watchlist
  • 39.530
  • -0.370-0.93%
Close Jan 22 16:00 ET
  • 39.530
  • 0.0000.00%
Post 20:01 ET
6.07BMarket Cap-19.28P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cogent Biosciences (COGT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
10.53%83.36M
17.39%75.58M
20.08%74.93M
32.58%275.94M
26.63%73.73M
26.58%75.41M
36.75%64.39M
44.33%62.4M
40.78%208.13M
33.11%58.23M
Selling and administrative expenses
21.75%14.37M
32.56%13.38M
22.73%11.9M
25.91%43.28M
22.93%11.69M
24.83%11.8M
22.88%10.09M
34.73%9.7M
31.14%34.38M
35.78%9.51M
-General and administrative expense
21.75%14.37M
32.56%13.38M
22.73%11.9M
25.91%43.28M
22.93%11.69M
24.83%11.8M
22.88%10.09M
34.73%9.7M
31.14%34.38M
35.78%9.51M
Research and development costs
8.45%68.99M
14.57%62.2M
19.59%63.03M
33.90%232.66M
27.35%62.05M
26.91%63.61M
39.68%54.29M
46.25%52.71M
42.86%173.76M
32.60%48.72M
Operating profit
-10.53%-83.36M
-17.39%-75.58M
-20.08%-74.93M
-32.58%-275.94M
-26.63%-73.73M
-26.58%-75.41M
-36.75%-64.39M
-44.33%-62.4M
-40.78%-208.13M
-33.11%-58.23M
Net non-operating interest income expense
-49.19%2.43M
-61.82%2.06M
-27.24%2.95M
38.32%18.09M
-0.28%3.86M
13.84%4.78M
96.75%5.39M
78.88%4.06M
227.83%13.08M
83.41%3.87M
Non-operating interest income
-18.66%3.89M
-56.00%2.37M
-27.24%2.95M
38.32%18.09M
-0.28%3.86M
13.84%4.78M
96.75%5.39M
78.88%4.06M
227.83%13.08M
83.41%3.87M
Non-operating interest expense
--1.46M
--314K
----
----
----
--0
--0
----
----
----
Other net income (expense)
-400.00%-3K
-113.64%-6K
-400.00%-5K
-24.63%1.99M
27,928.57%1.95M
1K
-83.58%44K
-100.04%-1K
-26.77%2.64M
-100.35%-7K
Other non- operating income (expenses)
-400.00%-3K
-113.64%-6K
-400.00%-5K
-24.63%1.99M
27,928.57%1.95M
--1K
-83.58%44K
-100.04%-1K
-26.77%2.64M
-100.35%-7K
Income before tax
-14.58%-80.93M
-24.73%-73.53M
-23.37%-71.99M
-32.98%-255.86M
-24.95%-67.93M
-27.54%-70.63M
-33.75%-58.95M
-51.21%-58.35M
-37.20%-192.41M
-37.22%-54.37M
Income tax
Net income
-14.58%-80.93M
-24.73%-73.53M
-23.37%-71.99M
-32.98%-255.86M
-24.95%-67.93M
-27.54%-70.63M
-33.75%-58.95M
-51.21%-58.35M
-37.20%-192.41M
-37.22%-54.37M
Net income continuous Operations
-14.58%-80.93M
-24.73%-73.53M
-23.37%-71.99M
-32.98%-255.86M
-24.95%-67.93M
-27.54%-70.63M
-33.75%-58.95M
-51.21%-58.35M
-37.20%-192.41M
-37.22%-54.37M
Minority interest income
Net income attributable to the parent company
-14.58%-80.93M
-24.73%-73.53M
-23.37%-71.99M
-32.98%-255.86M
-24.95%-67.93M
-27.54%-70.63M
-33.75%-58.95M
-51.21%-58.35M
-37.20%-192.41M
-37.22%-54.37M
Preferred stock dividends
-1.99%-12.51M
-12.27M
Other preferred stock dividends
Net income attributable to common stockholders
-14.58%-80.93M
-24.73%-73.53M
-29.07%-59.47M
-32.98%-255.86M
-24.95%-67.93M
-27.54%-70.63M
-33.75%-58.95M
-19.41%-46.08M
-37.20%-192.41M
-37.22%-54.37M
Basic earnings per share
3.85%-0.5
-23.26%-0.53
-6.12%-0.52
0.00%-1.94
2.39%-0.6149
18.75%-0.52
27.12%-0.43
10.91%-0.49
-12.14%-1.94
-12.50%-0.63
Diluted earnings per share
3.85%-0.5
-23.26%-0.53
-6.12%-0.52
0.00%-1.94
2.39%-0.6149
18.75%-0.52
27.12%-0.43
10.91%-0.49
-12.14%-1.94
-12.50%-0.63
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 10.53%83.36M17.39%75.58M20.08%74.93M32.58%275.94M26.63%73.73M26.58%75.41M36.75%64.39M44.33%62.4M40.78%208.13M33.11%58.23M
Selling and administrative expenses 21.75%14.37M32.56%13.38M22.73%11.9M25.91%43.28M22.93%11.69M24.83%11.8M22.88%10.09M34.73%9.7M31.14%34.38M35.78%9.51M
-General and administrative expense 21.75%14.37M32.56%13.38M22.73%11.9M25.91%43.28M22.93%11.69M24.83%11.8M22.88%10.09M34.73%9.7M31.14%34.38M35.78%9.51M
Research and development costs 8.45%68.99M14.57%62.2M19.59%63.03M33.90%232.66M27.35%62.05M26.91%63.61M39.68%54.29M46.25%52.71M42.86%173.76M32.60%48.72M
Operating profit -10.53%-83.36M-17.39%-75.58M-20.08%-74.93M-32.58%-275.94M-26.63%-73.73M-26.58%-75.41M-36.75%-64.39M-44.33%-62.4M-40.78%-208.13M-33.11%-58.23M
Net non-operating interest income expense -49.19%2.43M-61.82%2.06M-27.24%2.95M38.32%18.09M-0.28%3.86M13.84%4.78M96.75%5.39M78.88%4.06M227.83%13.08M83.41%3.87M
Non-operating interest income -18.66%3.89M-56.00%2.37M-27.24%2.95M38.32%18.09M-0.28%3.86M13.84%4.78M96.75%5.39M78.88%4.06M227.83%13.08M83.41%3.87M
Non-operating interest expense --1.46M--314K--------------0--0------------
Other net income (expense) -400.00%-3K-113.64%-6K-400.00%-5K-24.63%1.99M27,928.57%1.95M1K-83.58%44K-100.04%-1K-26.77%2.64M-100.35%-7K
Other non- operating income (expenses) -400.00%-3K-113.64%-6K-400.00%-5K-24.63%1.99M27,928.57%1.95M--1K-83.58%44K-100.04%-1K-26.77%2.64M-100.35%-7K
Income before tax -14.58%-80.93M-24.73%-73.53M-23.37%-71.99M-32.98%-255.86M-24.95%-67.93M-27.54%-70.63M-33.75%-58.95M-51.21%-58.35M-37.20%-192.41M-37.22%-54.37M
Income tax
Net income -14.58%-80.93M-24.73%-73.53M-23.37%-71.99M-32.98%-255.86M-24.95%-67.93M-27.54%-70.63M-33.75%-58.95M-51.21%-58.35M-37.20%-192.41M-37.22%-54.37M
Net income continuous Operations -14.58%-80.93M-24.73%-73.53M-23.37%-71.99M-32.98%-255.86M-24.95%-67.93M-27.54%-70.63M-33.75%-58.95M-51.21%-58.35M-37.20%-192.41M-37.22%-54.37M
Minority interest income
Net income attributable to the parent company -14.58%-80.93M-24.73%-73.53M-23.37%-71.99M-32.98%-255.86M-24.95%-67.93M-27.54%-70.63M-33.75%-58.95M-51.21%-58.35M-37.20%-192.41M-37.22%-54.37M
Preferred stock dividends -1.99%-12.51M-12.27M
Other preferred stock dividends
Net income attributable to common stockholders -14.58%-80.93M-24.73%-73.53M-29.07%-59.47M-32.98%-255.86M-24.95%-67.93M-27.54%-70.63M-33.75%-58.95M-19.41%-46.08M-37.20%-192.41M-37.22%-54.37M
Basic earnings per share 3.85%-0.5-23.26%-0.53-6.12%-0.520.00%-1.942.39%-0.614918.75%-0.5227.12%-0.4310.91%-0.49-12.14%-1.94-12.50%-0.63
Diluted earnings per share 3.85%-0.5-23.26%-0.53-6.12%-0.520.00%-1.942.39%-0.614918.75%-0.5227.12%-0.4310.91%-0.49-12.14%-1.94-12.50%-0.63
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -